XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 26, 2022
Jun. 27, 2021
Jun. 28, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income $ 4,605,286 $ 3,908,458 $ 2,251,753
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 333,739 307,151 268,525
Deferred income taxes (257,438) (151,477) (17,777)
Equity-based compensation expense 259,064 220,164 189,197
Other, net (44,751) (17,392) 6,628
Changes in operating asset and liability accounts:      
Accounts receivable, net of allowance (1,287,680) (928,928) (641,827)
Inventories (1,351,344) (792,591) (411,608)
Prepaid expenses and other assets (53,121) (59,189) (14,354)
Trade accounts payable 167,884 184,615 208,478
Deferred profit 604,573 508,008 76,207
Accrued expenses and other liabilities 123,462 409,344 211,229
Net cash provided by operating activities 3,099,674 3,588,163 2,126,451
CASH FLOWS FROM INVESTING ACTIVITIES:      
Capital expenditures and intangible assets (546,034) (349,096) (203,239)
Purchases of available-for-sale securities (567,819) (3,389,388) (2,897,627)
Proceeds from maturities of available-for-sale securities 190,269 2,381,758 1,647,379
Proceeds from sales of available-for-sale securities 1,543,434 1,472,152 1,235,248
Other, net (7,575) (42,155) (25,845)
Net cash provided by (used for) investing activities 612,275 73,271 (244,084)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Principal payments on long-term debt and finance lease obligations and payments for debt issuance costs (11,889) (862,060) (667,537)
Net proceeds from issuance of long-term debt 0 0 1,974,651
Proceeds from borrowings on revolving credit facility 0 0 1,250,000
Repayment of borrowings on revolving credit facility 0 0 (1,250,000)
Treasury stock purchases (3,865,663) (2,697,704) (1,369,649)
Dividends paid (815,290) (726,992) (656,838)
Reissuances of treasury stock related to employee stock purchase plan 108,178 97,764 85,439
Proceeds from issuance of common stock 5,682 24,123 8,084
Other, net 45 (2,113) 1,920
Net cash used for financing activities (4,578,937) (4,166,982) (623,930)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (30,227) 7,215 (2,750)
Net (decrease) increase in cash, cash equivalents and restricted cash (897,215) (498,333) 1,255,687
Cash, cash equivalents and restricted cash at beginning of year 4,670,750 5,169,083 3,913,396
Cash, cash equivalents and restricted cash at end of year 3,773,535 4,670,750 5,169,083
Schedule of non-cash transactions      
Accrued payables for stock repurchases 46 20,005 82
Accrued payables for capital expenditures 80,296 61,392 37,812
Dividends payable 205,615 185,431 167,129
Transfers of finished goods inventory to property and equipment 75,068 80,252 51,694
Supplemental disclosures:      
Cash payments for interest 175,528 203,932 171,889
Cash payments for income taxes, net 807,669 518,567 222,909
Reconciliation of cash, cash equivalents, and restricted cash      
Cash and cash equivalents 3,522,001 4,418,263 4,915,172
Restricted cash and cash equivalents 251,534 252,487 253,911
Total cash, cash equivalents, and restricted cash $ 3,773,535 $ 4,670,750 $ 5,169,083